Literature DB >> 338489

Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness.

T R Kozel, W F Gulley, J Cazin.   

Abstract

Mice injected with 100 to 800 microgram of Cryptococcus neoformans soluble polysaccharide showed a reduced ability to produce antibody after a challenge immunization with polysaccharide emulsified in Freund incomplete adjuvant. These animals were considered immunologically unresponsive. Animals given an initial injection of 25 or 50 microgram of polysaccharide responded to a challenge immunization in the same manner as control animals. Reversion of unresponsive mice to antibody production without further antigenic stimulation did not occur during a 12-week experimental period. These animals exhibited a partial response to challenge immunization 8 weeks after induction of unresponsiveness, and they were fully responsive to challenge immunization at 12 weeks. Animals given a single dose of 0.1, 0.4, or 1.6 microgram of polysaccharide produced a marked anamnestic response after challenge immunization. Repeated injections of subimmunogenic doses of polysaccharide did not produce a marked anamnestic response and would induce unresponsiveness only when the cumulative dose reached 100 to 400 microgram of polysaccharide, suggesting that injected cryptococcal polysaccharide might be sequestered in some manner until an amount of antigen sufficient for induction of unresponsiveness is accumulated. This possibility was confirmed by immunofluorescence studies that revealed a long-term deposition of polysaccharide in the tubular epithelial cells of the kidney.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 338489      PMCID: PMC421292          DOI: 10.1128/iai.18.3.701-707.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Antibody-dependent killing of Cryptococcus neopormans by human peripheral blood mononuclear cells.

Authors:  R D Diamond
Journal:  Nature       Date:  1974-01-18       Impact factor: 49.962

2.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.

Authors:  R D Diamond; R K Root; J E Bennett
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

3.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

4.  Serology of human cryptococcosis.

Authors:  D D Bindschadler; J E Bennett
Journal:  Ann Intern Med       Date:  1968-07       Impact factor: 25.391

5.  Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.

Authors:  R D Diamond; A C Allison
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

6.  Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

7.  Immune response to Cryptococcus neoformans soluble polysaccharide. I. Serological assay for antigen and antibody.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

8.  Value and interpretation of serological tests for the diagnosis of cryptococcosis.

Authors:  L Kaufman; S Blumer
Journal:  Appl Microbiol       Date:  1968-12

9.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03

10.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

View more
  48 in total

1.  Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.

Authors:  D L Goldman; S C Lee; A J Mednick; L Montella; A Casadevall
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

3.  Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice.

Authors:  G Nussbaum; S Anandasabapathy; J Mukherjee; M Fan; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure.

Authors:  Alena Janda; Arturo Casadevall
Journal:  Mol Immunol       Date:  2010-03-17       Impact factor: 4.407

Review 5.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 6.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

7.  Cryptococcal capsular polysaccharide clearance in nonimmune mice.

Authors:  H G Muchmore; E N Scott; F G Felton; R A Fromtling
Journal:  Mycopathologia       Date:  1982-04-23       Impact factor: 2.574

8.  Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.

Authors:  D L Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis.

Authors:  S C Lee; A Casadevall; D W Dickson
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

10.  Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Authors:  J Mukherjee; L S Zuckier; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.